Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -12.20
- Piotroski Score 2.00
- Grade Neutral
- Symbol (FREQ)
- Company Frequency Therapeutics, Inc.
- Price $0.30
- Changes Percentage (4.76%)
- Change $0.01
- Day Low $0.28
- Day High $0.32
- Year High $5.59
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/01/2023
- Fiscal Year End N/A
- Average Stock Price Target $7.00
- High Stock Price Target $7.00
- Low Stock Price Target $7.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.90
- Trailing P/E Ratio -0.15768421052632
- Forward P/E Ratio -0.15768421052632
- P/E Growth -0.15768421052632
- Net Income $-81,580,000
Income Statement
Quarterly
Annual
Latest News of FREQ
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Southern California homeowner shot and killed bear that frequently...
A homeowner in Southern California shot and killed a bear attempting to break into his chicken coop. Despite community concerns, the homeowner was legally permitted to do so under California law. The ...
By New York Post | 4 days ago -
Best gifts for frequent travelers | TechCrunch
The best gift for someone is the gift of travel or items to enhance the travel experience, especially for frequent travelers. Recommended gadgets include AirTags, Bose QuietComfort Ultra headphones, M...
By TechCrunch | 1 week ago -
Holiday Gift Guide 2024: The Ideal Men's Self Care Gifts For Frequent Fliers
Self-care for frequent travelers goes beyond skincare and vitamins. Consider travel-friendly products like TSA-friendly toiletries, plant-based nutrition supplements, and skincare kits for a healthy a...
By Forbes | 1 week ago
